person

Ebrahim N.

Country
Hungary
Department
3604: II. Belgyogyaszat

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
562
Sites with multiple studies

Has run more than one trial at 562 of 1175 partner sites.

Specializations

Cardiovascular Disease Management

The investigator specializes in treating various forms of cardiovascular disease, with particular emphasis on heart failure management across different patient populations. Their research encompasses both chronic heart failure with reduced ejection fraction and prevention strategies.

  • Heart Failure Treatment Innovation
  • Cardiovascular Mortality Reduction
  • Myocardial Infarction Care

Their work extends to evaluating novel therapeutic approaches for anterior ST-elevation myocardial infarction and atrial fibrillation.

Renal Medicine

The investigator focuses on chronic kidney disease treatment, particularly in patients with concurrent hypertension. Their research investigates innovative therapeutic combinations to slow disease progression and improve patient outcomes.

  • CKD Progression Management
  • Renal Function Preservation
  • Hypertension Control in CKD

Special attention is given to the interaction between kidney function and cardiovascular health in complex patient cases.

Metabolic Disorders

The investigator's expertise includes the treatment of Type 2 Diabetes Mellitus with specific focus on cardiovascular risk reduction. They also study lipoprotein disorders and their impact on cardiovascular outcomes.

  • Diabetes Management
  • Cardiovascular Risk Reduction
  • Lipid Disorder Treatment

Their research explores innovative therapeutic approaches for managing complex metabolic conditions with cardiovascular complications.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.